Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy (Q34825007)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

type-1 diabetes

0 references

type 2 diabetes

0 references

author name string

Hans-Henrik Parving

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Peter Hovind

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Current Hypertension Reports

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

387-393

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0069-3

21 January 2018

Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0069-3

21 January 2018

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0069-3

21 January 2018

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective study of microalbuminuria as predictor of mortality in NIDDM

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of diabetic renal disease with special reference to microalbuminuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initiation and progression of diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic nephropathy: prevention and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microalbuminuria predicts mortality in non-insulin-dependent diabetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morbidity, mortality, and albuminuria in type 2 diabetic patients: a three-year prospective study of a random cohort in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/12217258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11906-002-0069-3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34825007&oldid=2197057900"